IN8BIO, INC. (INAB) Form 10-Q Quarterly Reports
IN8BIO, INC. (INAB) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INAB
CIK: 1740279
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CohnReznick LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerCharles Kavanagh
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000935836-26-000398 | View SEC Doc Filr Page |
| S-8 | 2026-08-07 | — | S-8 | 0001193125-26-338511 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338012 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-337944 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-05-29 | 8-K | 0001193125-26-249684 | View SEC Doc Filr Page |
| 424B5 | 2026-06-01 | — | 424B5 | 0001193125-26-249564 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-29 | — | SCHEDULE 13D/A Filing | 0001682638-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 Filing | 0001682638-26-000006 | View SEC Doc Filr Page |
| EFFECT | 2026-05-19 | — | EFFECT Filing | 9999999995-26-001697 | View SEC Doc Filr Page |
| S-3/A | 2026-05-18 | — | S-3/A | 0001193125-26-229132 | View SEC Doc Filr Page |
| CORRESP | 2026-05-15 | — | CORRESP Filing | 0001193125-26-225869 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001830914-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001853815-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001830059-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001682638-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001874384-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001898521-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001839156-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001434099-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-09 | 4 Filing | 0001975028-26-000002 | View SEC Doc Filr Page |
| S-8 POS | 2026-05-07 | — | S-8 POS | 0001193125-26-212454 | View SEC Doc Filr Page |
| S-8 POS | 2026-05-07 | — | S-8 POS | 0001193125-26-212451 | View SEC Doc Filr Page |
| S-8 POS | 2026-05-07 | — | S-8 POS | 0001193125-26-212447 | View SEC Doc Filr Page |
| S-8 POS | 2026-05-07 | — | S-8 POS | 0001193125-26-212444 | View SEC Doc Filr Page |
| S-8 POS | 2026-05-07 | — | S-8 POS | 0001193125-26-212441 | View SEC Doc Filr Page |